Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Nederland
  4. Euronext Amsterdam
  5. Pharming Group N.V.
  6. Nieuws
  7. Andere talen
    PHARM   NL0010391025

PHARMING GROUP N.V.

(PHARM)
Real-time koersen. Real Time Euronext Amsterdam - 22/10 17:35:26
0.802 EUR   -2.05%
22/10BEURSAGENDA : Nederlandse bedrijven
AM
22/10BEURSAGENDA : Nederlandse bedrijven
AM
21/10BEURSAGENDA : Nederlandse bedrijven
AM
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Nieuws in andere talen op PHARMING GROUP N.V.
22/10PHARMING N : Pharming Group Notice of 9M Results
22/10PHARMING N : Group Notice of 9M Results
14/10JPMorgan opens South Korea commercial banking office in international expansion
14/09PHARMING N : Pharming announces results from clinical trials for the treatment of COVID-19..
14/09PHARMING N : announces results from clinical trials for the treatment of COVID-19 with RUC..
14/09Pharming Announces Results from Clinical Trials for the Treatment of COVID-19 with RUCO..
05/08Pharming to Seek Acquisitions
05/08PHARMING N : Group reports financial results for the first half of 2021
29/07SIGN UP NOW : Pharming's Half Year Financial Results Webinar
20/07PHARMING N : signs agreement with NewBridge Pharmaceuticals for the commercialization of R..
20/07Pharming Signs Agreement with Newbridge Pharmaceuticals for the Commercialization of Ru..
01/07ORCHARD THERAPEUTICS : to Collaborate With Pharming Group on Treatment for Hereditary Angi..
01/07PHARMING N : Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and..
01/07ORCHARD THERAPEUTICS : and Pharming Group Announce Collaboration to Develop and Commercial..
01/07Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercia..
01/07Orchard Therapeutics plc announced that it expects to receive $7.5 million in funding f..
23/06PHARMING N : Pharming announces completion of enrolment in Phase II/III study with lenioli..
23/06PHARMING N : announces completion of enrolment in Phase II/III study with leniolisib for a..
23/06Pharming Group N.V Announces Completion of Enrolment in Phase II/III Study with Lenioli..
21/06PHARMING GROUP N.V.(ENXTAM : PHARM) added to Netherlands ASCX AMS Small Cap Index
18/06PHARMING N : appoints Anurag Relan as Chief Medical Officer and Robert Friesen as Chief Sc..
18/06Pharming Group N.V. Announces Executive Changes
18/06PHARMING GROUP N.V.(ENXTAM : PHARM) dropped from AMX Index
04/06PHARMING N : announces the reimbursement of RUCONESTģ in Spain
01/06PHARMING N : Group to present at Jefferies Virtual Healthcare Conference
19/05Pharming Group N.V. Announces Executive Changes
13/05Pharming Group N.V. Reports Earnings Results for the First Quarter Ended March 31, 2021
13/05PHARMING N : Group reports financial results for the first quarter of 2021
13/05PHARMING GROUP N.V. : des résultats sans saveur
22/04Pharming Group N.V Announces Enrolment of First Patient in Multicentre Phase IIb Clinic..
23/03Pharming Group N.V. Announces Board Changes
08/03PHARMING N : Phishing, Pharming, Malware, And Other Internet Delights
04/03Pharming Group Seeks Acquisitions
04/03Pharming Group N.V. Reports Earnings Results for the Full Year Ended December 31, 2020
04/03Pharming Group N.V. Provides Earnings Guidance for the Remainder of 2021
02/03PHARMING N : Group, in collaboration with Invitae Corporation, launches genetic testing pr..
02/03Pharming Group N.V. in Collaboration with Invitae Corporation, Launches Genetic Testing..
2020PHARMING GROUP N.V.(NASDAQGM : PHAR) added to NASDAQ Composite Index
2020PHARMING N : Group announces ADSs admitted to trade on Nasdaq under the symbol “PHAR..
2020PHARMING N : Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq List..
2020PHARMING N : Reports on Extraordinary General Meeting of Shareholders
2020Pharming Group N.V. Announces Board Appointments
2020PHARMING N : announces enrolment of first patient in US clinical trial for the treatment o..
2020Pharming Group N.V. Announces Enrolment of First Patient in US Clinical Trial for the T..
2020PHARMING N : Juergen Ernst to retire from Pharming's Board of Supervisory Directors after ..
2020Pharming Group N.V. Announces Management Changes
2020PHARMING N : announces commitment to build a new downstream manufacturing facility for RUC..
2020Pharming Group N.V. Announces Commitment to Build A New Downstream Manufacturing Facili..
2020PHARMING N : appoints Jeroen Wakkerman as Chief Financial Officer
2020Pharming Group N.V. Appoints Jeroen Wakkerman as Chief Financial Officer, Effective 16 ..
2020PHARMING N : Group reports financial results for the first nine months of 2020
2020PHARMING N : convenes Extraordinary General Meeting of shareholders
2020Pharming Group N.V. Provides Earnings Guidance for the Remainder of 2020
2020Pharming Group N.V. Reports Earnings Results for the Nine Months Ended September 30, 20..
2020PHARMING N : receives Orphan Drug Designation from the European Commission for leniolisib ..
2020Pharming Receives Orphan Drug Designation from the European Commission for Leniolisib f..
2020PHARMING N : announces the publication of data from a compassionate use programme of RUCON..
2020Pharming Announces the Publication of Data from a Compassionate Use Programme of RUCONE..
2020PHARMING N : announces enrolment of first patient in multinational clinical trial for the ..
2020Pharming Group N.V. Announces Enrolment of First Patient in Multinational Clinical Tria..
2020ORIGINAL-RESEARCH : Pharming Group NV (von First Berlin Equity Research GmbH):...
2020PHARMING N : Group reports financial results for the first half of 2020
2020Pharming Group N.V. Provides Earnings Guidance for the Remainder of 2020
2020Pharming Group N.V. Reports Earnings Results for the Half Year Ended June 30, 2020
2020Pharming Group Announces the Nomination of Barbara Yanni and Mark Pykett to the Board o..
2020ORIGINAL-RESEARCH : Pharming Group NV (von First Berlin Equity Research GmbH):...
2020Pharming Group N.V. Provides Sales Guidance for the Remainder of 2020
2020Pharming Group N.V. Reports Earnings Results for the First Quarter Ended March 31, 2020
2020Pharming Group Receives European Commission Approval for Treatment of Acute Hereditary ..
2020ORIGINAL-RESEARCH : Pharming Group NV (von First Berlin Equity Research GmbH):...
2020PHARMING N : Seven Ways to Rob You during COVID-19
2020PHARMING GROUP N.V. : bondit sur des résultats précoces avec Ruconest sur des patients tou..
2020PHARMING N : reports encouraging results from use of RUCONESTģ in COVID-19 patients
2020Pharming Group N.V. Reports Encouraging Results From Use of RUCONESTģ in COVID-19 Patie..
2020PHARMING N : Group convenes Annual General Meeting of shareholders
1  2  3  4Volgende
Volgende evenement op PHARMING GROUP N.V.
Komende gebeurtenissen in de sector